Skip to main content

Table 2 Demographics among patients with elevated depression symptoms at baseline (and at least 2 PHQ-9 scores in the first 6 months)

From: Factors associated with response and remission from depression at 6-months of treatment in a retrospective cohort treated within an integrated care program

Demographics (N = 615)

N (%)

Gender

 Male

211 (34.31)

 Female

404 (65.69)

Ethnicity

 Hispanic/Latino

99 (16.10)

 Not Hispanic/Latino

458 (74.47)

 Missing

58 (9.43)

Race

 White/Caucasian

354 (57.56)

 Asian

54 (8.78)

 Black/African American

35 (5.69)

 Two or More Races

19 (3.09)

 Other/Unknowna

153 (24.88)

Marital Status

 Married/Domestic Partner

209 (33.98)

 Previously Married/Domestic Partner

40 (6.50)

 Single

348 (56.59)

 Otherb

18 (2.93)

Age

 Age at Baseline, Mean (SD)

40.51 (14.82)

Baseline Depression Symptoms

 PHQ-9 Score, Mean (SD)

15.87 (4.56)

Suicidal Ideation at Baseline

 Yesc

248 (40.33)

Treatment Response by 6-month Follow-up

 PHQ-9 Score < 5

100 (16.26)

 PHQ-9 Score < 10

289 (46.99)

 Reduction in PHQ-9 Score ≥ 6

277 (45.04)

Other Clinical Symptoms at Baselined,e

 GAD-7 Score ≥ 10

434 (70.57)

 AUDIT-C Score ≥ 3f

228 (37.07)

 DAST-10 Score ≥ 3g

64 (10.41)

 PCL Score > 50

174 (28.29)

Number of Treatment Sessions

 Total, Mean (SD)h

7.29 (4.04)

 With a Physician, Mean (SD)

2.81 (2.02)

 With a Therapist, Mean (SD)

3.91 (4.33)

  1. a “Other/Unknown” includes: “American Indian or Alaska Native”, “Native Hawaiian or Other Pacific Islander”, “Other”, “Unknown”
  2. b “Other” includes: Life Partner, Significant Other, Unknown, Other, Missing
  3. c Includes any endorsement on PHQ-9 item 9 except “Not at all”
  4. d Percentage is out of the total N = 615, though some patients had a missing value on the AUDIT-C, DAST-10, and/or PCL
  5. e For the purposes of the analyses, patients who did not meet screening criteria for a given measure were given a “No” on meeting a clinical threshold (rather than given a missing status)
  6. f Clinical cutoff is ≥3 for females, ≥ 4 for males
  7. g Cutoff ≥3 indicates at least “moderate” symptoms; patients were only administered the DAST-10 if they screened positive on the 1-item screener
  8. h Includes visits that did not indicate a provider type